CIK 0001479681
- Accelerated filer
Nutex Health Inc.
Sign in to watch- Ticker
- NUTX
- Exchange
- Nasdaq
- Industry
- Services-Business Services, NEC
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 113363609
- Phone
- +1 713-660-0557
- Business address
- 1776 YORKTOWN ST, SUITE 700, HOUSTON, TX, 77056
- Former names
- Nutex Health, Inc., Clinigence Holdings, Inc., iGambit, Inc.
- 4 Open-market buy Chief Financial Officer bought 1,350 shares at $21.46 ($28,970)
- 4 Open-market buy Chief Operating Officer bought 1,875 shares at an average $17.71 ($33,210)
- 4 Grant or award Chief Executive Officer acquired 22,709 shares (grant or award)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4/A Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Open-market buy Chief Operating Officer bought 20,000 shares at $0.54 ($10,800)
- 4 Open-market buy Chief Executive Officer bought 72,478 shares at an average $0.69 ($50,367)
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 4 Exercise or conversion Chief Financial Officer acquired 49,505 shares (option exercise)
- 4 Exercise or conversion Chief Legal Officer acquired 16,502 shares (option exercise)
- 4 Open-market buy Chief Executive Officer bought 500,000 shares at an average $0.23 ($113,899)
- 4 Open-market buy Chief Operating Officer bought 140,000 shares at $0.24 ($34,174)
- 3 Insider Initial Statement of Ownership
Page 3 of 9 · 180 filings